Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention 2022-05-11 20:00
Bridge Biotherapeutics to Announce Updated Data from its Phase 1 Study of BBT-176 in Advanced Non-Small Cell Lung Cancer in an Oral Presentation at IASLC 2022 World Conference on Lung Cancer 2022-05-10 21:00
Nature Medicine Publishes Results from an Investigator-Initiated Trial of CARsgen's CT041 Claudin18.2 CAR T Cells in Gastrointestinal Cancers 2022-05-10 20:50
Harbour BioMed to Present the Latest Progress of Next-Generation Anti-CTLA-4 Antibody HBM4003 at 2022 ASCO Annual Meeting 2022-05-10 16:54
AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau 2022-05-10 09:00
Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy 2022-05-10 03:00
iNtRON Biotechnology, Inc., Launches New Website 2022-05-09 21:00
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital 2022-05-09 11:37
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board 2022-05-06 08:00
AHRA and United Imaging launch a new program to develop exceptional leaders. 2022-05-05 22:15
Daewoong Pharmaceutical announced first-quarter 2022 results 2022-05-05 21:00
I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act 2022-05-05 20:00
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act 2022-05-05 17:18
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
United Imaging Flips the Script on its Events Program for 2022, Reveals Expanded Sales Force and U.S. Growth 2022-05-03 23:22
Inmagene Receives FDA's IND Clearance for OX40 Antagonist 2022-05-01 06:00
Concord Medical Files 2021 Annual Report on Form 20-F 2022-04-30 07:15
IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors 2022-04-29 20:00
I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer 2022-04-29 04:01
1 129 130 131 132 133 432